Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Clinical trial NCT02273661 · COMPLETED
Trial details
- NCT number
- NCT02273661
- Sponsor
- Poitiers University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-19
- Primary completion
- 2019-06-28
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.